Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test may steer chemo choices for metastatic breast cancer

NCT ID NCT01349842

Completed Knowledge-focused Sponsor: Institut Curie Source: ClinicalTrials.gov ↗

First seen Nov 25, 2025 · Last updated Apr 25, 2026 · Updated 19 times

Summary

This study looked at whether measuring circulating tumor cells (CTCs) in the blood can help doctors decide when to switch chemotherapy for women with metastatic breast cancer. 265 women who had already tried two chemotherapy treatments took part. The goal was to see if using CTC counts to guide treatment could improve overall survival compared to standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER DUCTAL INFILTRATING METASTATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Centre Georges Francois Leclerc

    Dijon, 21079, France

  • Chu Limoges

    Limoges, 87042, France

  • Clinique Victor Hugo

    Le Mans, 72000, France

  • Hopital Saint Louis

    Paris, 75475, France

  • Institut Curie

    Paris, 75005, France

  • Institut Rene Huguenin Curie

    Saint-Cloud, 92210, France

  • Institut de Canacerologie de L'Ouest

    Saint-Herblain, 44805, France

Conditions

Explore the condition pages connected to this study.

BREAST CANCER DUCTAL INFILTRATING METASTATIC